🇺🇸 FDA
Patent

US 11851436

Fused bicyclic pyrimidine derivatives and uses thereof

granted A61PA61P35/00

Quick answer

US patent 11851436 (Fused bicyclic pyrimidine derivatives and uses thereof) held by The Regents of the University of Colorado, a Body Corporate expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P35/00